+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Voya Infrastructure

(NYSE:IDE)

Intraday

$10.23

0.01[0.10%]

After-Hours

$10.23

0[0.00%]

Perks Buy Compare Brokers

$10.23

0.01[0.10%]

At close: May 16

$10.23

0[0.00%]

After Hours: 4:00PM EDT

The dividend Ex-Date is in 14 days

Overview News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest News for Voya Infrastructure Stock (NYSE:IDE)

Voya Infrastructure Stock (NYSE: IDE)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, October 07, 2022

Stocks That Hit 52-Week Lows On Friday
Benzinga Insights - Oct 7, 2022, 2:27PM

Tuesday, July 05, 2022

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights - Jul 5, 2022, 12:09PM

Friday, July 01, 2022

Stocks That Hit 52-Week Lows On Friday
Benzinga Insights - Jul 1, 2022, 2:47PM

Wednesday, May 11, 2022

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - May 11, 2022, 12:28PM

Friday, May 06, 2022

Stocks That Hit 52-Week Lows On Friday
Benzinga Insights - May 6, 2022, 12:06PM

Wednesday, June 16, 2021

Stocks That Hit 52-Week Highs On Wednesday
Benzinga Insights - Jun 16, 2021, 10:03AM

Tuesday, May 25, 2021

Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights - May 25, 2021, 10:52AM

Monday, May 24, 2021

Stocks That Hit 52-Week Highs On Monday
Benzinga Insights - May 24, 2021, 10:04AM

Thursday, May 20, 2021

Stocks That Hit 52-Week Highs On Thursday
Benzinga Insights - May 20, 2021, 10:27AM

Wednesday, March 31, 2021

Stocks That Hit 52-Week Highs On Wednesday
Benzinga Insights - Mar 31, 2021, 10:05AM

Monday, March 01, 2021

Stocks That Hit 52-Week Highs On Monday
Benzinga Insights - Mar 1, 2021, 11:17AM

Friday, February 26, 2021

Stocks That Hit 52-Week Highs On Friday
Benzinga Insights - Feb 26, 2021, 10:22AM

Thursday, February 25, 2021

Stocks That Hit 52-Week Highs On Thursday
Benzinga Insights - Feb 25, 2021, 10:18AM

Tuesday, June 09, 2020

UPDATE: Ideanomics Says Total Value Of Autos Sold In May Out Of Mobile Energy Global Expo Center $33M
Benzinga Newsdesk - Jun 9, 2020, 8:45AM

Monday, March 23, 2020

Stocks That Hit 52-Week Lows On Monday
Lisa Levin - Mar 23, 2020, 10:34AM

Thursday, March 19, 2020

Stocks That Hit 52-Week Lows On Thursday
Lisa Levin - Mar 19, 2020, 10:49AM

Wednesday, March 18, 2020

Stocks That Hit 52-Week Lows On Wednesday
Lisa Levin - Mar 18, 2020, 11:37AM

Monday, March 16, 2020

Stocks That Hit 52-Week Lows On Monday
Lisa Levin - Mar 16, 2020, 11:51AM

Thursday, March 12, 2020

Stocks That Hit 52-Week Lows On Thursday
Lisa Levin - Mar 12, 2020, 12:10PM

Friday, February 28, 2020

Stocks That Hit 52-Week Lows On Friday
Lisa Levin - Feb 28, 2020, 10:16AM

Thursday, February 27, 2020

Stocks That Hit 52-Week Lows On Thursday
Lisa Levin - Feb 27, 2020, 10:23AM

Wednesday, December 19, 2018

Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
Benzinga Newsdesk - Dec 19, 2018, 12:43PM

Monday, December 17, 2018

Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
Benzinga Newsdesk - Dec 17, 2018, 11:48AM

Monday, October 29, 2018

Stocks Which Set New 52-Week Low Friday, October 26th
Benzinga Newsdesk - Oct 29, 2018, 9:56AM

Wednesday, October 24, 2018

Stocks Which Set New 52-Week Low Yesterday, October 23rd
Benzinga Newsdesk - Oct 24, 2018, 10:06AM

Friday, October 12, 2018

Stocks Which Set New 52-Week Low Yesterday, October 11th
Benzinga Newsdesk - Oct 12, 2018, 11:30AM

Thursday, October 11, 2018

Stocks Which Set New 52-Week Low Yesterday, October 10th
Benzinga Newsdesk - Oct 11, 2018, 9:11AM

Monday, June 16, 2014

CR Bard's Lutonix DCB Moves Closer To FDA Clearance - Analyst Blog
Benzinga - Jun 16, 2014, 7:45AM

Thursday, June 05, 2014

ABIOMED Impella Platform Crosses 20K Mark - Analyst Blog
Benzinga - Jun 5, 2014, 6:10PM

Tuesday, May 27, 2014

St. Jude Medical's PORTICO Trial Under Way - Analyst Blog
Benzinga - May 27, 2014, 2:50PM

Wednesday, March 26, 2014

St. Jude Medical's Prodigy Neurostimulator Gets CE Mark - Analyst Blog
Benzinga - Mar 26, 2014, 4:51PM

Monday, March 24, 2014

ABIOMED's Impella Trial Achieves Enrollment Target - Analyst Blog
Benzinga - Mar 24, 2014, 4:10PM

Friday, March 21, 2014

St. Jude Medical Initiates Nanostim Pacemaker Trial - Analyst Blog
Benzinga - Mar 21, 2014, 1:50PM

Tuesday, December 20, 2011

Bard Acquires Lutonix for $225M
Benzinga - Dec 20, 2011, 4:05PM

Wednesday, October 05, 2011

Biotech and Pharma Stock News; Aethlon Announces Hemopurifier® and HER2osome™ Cancer Therapy Presentation
Benzinga - Oct 5, 2011, 11:46AM

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved